This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Endocrine Diseases  • Diabetes Mellitus  • Statistics and Research Methods  • Hypertension  • Glaucoma  • Ophthalmological Disorders, Other  • Alert me on articles by topic

Mae O. Gordon, PhD; Julia A. Beiser; Michael A. Kass, MD; for the Ocular Hypertension Treatment Study Group

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In 2002, the Ocular Hypertension Treatment Study¹ (OHTS) reported baseline factors that increased the risk for developing primary open-angle glaucoma (POAG): older age, a larger vertical cup-disc ratio, higher intraocular pressure, greater Humphrey visual field pattern standard deviation, and a thinner central corneal measurement. A history of diabetes mellitus at baseline appeared to be protective against developing POAG. Six of the 191 participants (3.1%) who reported diabetes mellitus at baseline developed POAG compared with 119 of the 1427 participants (8.3%) who did not (multivariate hazard ratio, 0.37; 95% confidence interval, 0.15-0.90). This finding was unexpected and contradicted most of the literature on risk factors for POAG.^2-4

The 2002 article acknowledged methodological issues in the OHTS that might account for this finding. Participants were classified at baseline as having a positive history of . . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION

RELATED ARTICLES

Misclassification: Who Really Lives in This Neighborhood?
Alfred Sommer
Arch Ophthalmol. 2008;126(2):265-266.
EXTRACT | FULL TEXT  

The Ocular Hypertension Treatment Study: Baseline Factors That Predict the Onset of Primary Open-Angle Glaucoma
Mae O. Gordon, Julia A. Beiser, James D. Brandt, Dale K. Heuer, Eve J. Higginbotham, Chris A. Johnson, John L. Keltner, J. Philip Miller, Richard K. Parrish II, M. Roy Wilson, Michael A. Kass, and for the Ocular Hypertension Treatment Study Group
Arch Ophthalmol. 2002;120(6):714-720.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diabetes and Glaucoma
Kass et al.
Arch Ophthalmol 2008;126:746-747.
FULL TEXT  

Misclassification: Who Really Lives in This Neighborhood?
Sommer
Arch Ophthalmol 2008;126:265-266.
FULL TEXT